Syra Health (NASDAQ:SYRA – Get Free Report) is expected to be releasing its Q2 2026 results before the market opens on Thursday, August 6th. Analysts expect Syra Health to post earnings of ($0.09) per share and revenue of $2.20 million for the quarter. Parties may review the information on the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Friday, August 7, 2026 at 12:30 PM ET.
Syra Health Trading Down 3.3%
Shares of SYRA opened at $0.72 on Thursday. The stock has a market capitalization of $9.96 million, a P/E ratio of -1.11 and a beta of 2.94. The firm’s fifty day simple moving average is $0.59 and its two-hundred day simple moving average is $0.35. Syra Health has a 12 month low of $0.05 and a 12 month high of $1.15.
About Syra Health
Recommended Stories
- Five stocks we like better than Syra Health
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for Syra Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syra Health and related companies with MarketBeat.com's FREE daily email newsletter.
